Reports for BRISTOL-MYERS SQUIBB CANADA
Company Name
BRISTOL-MYERS SQUIBB CANADA
Totals |
||
Shortage reports |
36 |
|
| Actual shortage: | 1 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 17 (47%) | |
| Resolved: | 18 (50%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 5 (10%) | |
| Discontinued: | 46 (90%) | |
| Reversed: | 0 (0%) | |
Late reports |
0 (0%) |
|
Overdue reports |
3 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ZERIT - CAP 20MG | 20MG | CAPSULE | Resolved | 2018-07-13 | 2019-03-29 | 55662 |
| CEENU | 40MG | CAPSULE | Resolved | 2020-12-10 | 2021-01-28 | 130007 |
| SUSTIVA 50MG | 50MG | CAPSULE | Resolved | 2020-10-05 | 2020-12-11 | 125709 |
| SUNVEPRA | 100MG | CAPSULE | Resolved | 2017-07-11 | 2017-10-17 | 15472 |
| VIDEX EC | 250MG | CAPSULE (ENTERIC-COATED) | Avoided shortage | 2017-06-05 | 2017-07-04 | 11840 |
| MODECATE CONCENTRATE | 100mg | Liquid | Avoided shortage | 2017-03-10 | 2017-07-04 | 89 |
| MODECATE CONCENTRATE | 100MG | LIQUID | Resolved | 2018-02-08 | 2018-03-23 | 39130 |
| YERVOY | 5MG | LIQUID | Resolved | 2022-08-24 | 2023-03-08 | 167674 |
| YERVOY | 5MG | LIQUID | Resolved | 2023-07-12 | 2023-08-22 | 198397 |
| ABRAXANE FOR INJECTABLE SUSPENSION | 100MG | POWDER FOR SUSPENSION | Resolved | 2021-08-13 | 2022-03-28 | 144114 |
| ORENCIA | 125MG | SOLUTION | Resolved | 2020-11-23 | 2020-11-27 | 128713 |
| ORENCIA | 125MG | SOLUTION | Resolved | 2021-09-27 | 2021-10-14 | 146256 |
| ORENCIA | 125MG | SOLUTION | Actual shortage | 2024-03-18 | 2024-03-19 | 222656 |
| KENALOG-40 INJECTION 40MG/ML | 40MG | SUSPENSION | Resolved | 2022-01-07 | 2022-04-02 | 152339 |
| KENALOG-40 INJECTION 40MG/ML | 40MG | SUSPENSION | Resolved | 2022-05-16 | 2023-01-31 | 160669 |
| KENALOG-40 INJECTION 40MG/ML | 40MG | SUSPENSION | Resolved | 2022-08-04 | 2023-01-31 | 166071 |
| COUMADIN TAB 1MG | 1MG | TABLET | Resolved | 2018-03-14 | 2018-06-09 | 42860 |
| COUMADIN TAB 1MG | 1MG | TABLET | Avoided shortage | 2018-06-05 | 2018-08-21 | 51516 |
| COUMADIN TAB 1MG | 1MG | TABLET | Avoided shortage | 2020-01-09 | 2020-04-20 | 102828 |
| COUMADIN TAB 5MG | 5MG | TABLET | Avoided shortage | 2018-06-05 | 2018-07-23 | 51576 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CEFZIL TABLETS - 500MG | 500MG | TABLET | Discontinued | 2017-03-16 | 2017-08-01 | 3074 |
| CEFZIL TABLETS - 250MG | 250MG | TABLET | Discontinued | 2017-03-16 | 2017-07-01 | 3068 |
| PRAVACHOL | 40MG | TABLET | Discontinued | 2018-12-03 | 2020-12-01 | 68395 |
| PRAVACHOL | 40MG | TABLET | Discontinued | 2020-11-30 | 2020-12-02 | 129134 |
| COUMADIN TAB 3MG | 3MG | TABLET | Discontinued | 2017-09-21 | 2018-09-21 | 22997 |
| COUMADIN TAB 3MG | 3MG | TABLET | Discontinued | 2020-04-22 | 2020-09-01 | 112805 |
| COUMADIN TAB 6 MG | 6MG | TABLET | Discontinued | 2020-04-20 | 2020-07-11 | 112600 |
| SUSTIVA TABLETS | 600MG | TABLET | Discontinued | 2021-06-14 | 2022-10-01 | 140887 |
| DAKLINZA | 30MG | TABLET | To be discontinued | 2018-09-28 | 2018-09-28 | 62549 |
| DAKLINZA | 60MG | TABLET | To be discontinued | 2018-09-28 | 2018-09-28 | 62566 |
| EVOTAZ | 300MG 150MG | TABLET | Discontinued | 2017-09-21 | 2017-09-22 | 23000 |